Benjamin Lond
Research Associate
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (9)
Aim To design and develop a novel co‐produced intervention tool aimed at facilitating discussions that lung cancer nurses have with lung cancer patients about clinical trial opportunities; and promote trial recruitment. Design A multi‐phase qualitative focus group (phase 1) and co‐production (phase 2) study. Methods The rigorous design and content of the intervention tool was informed by qualitative data from seven focus groups with lung cancer healthcare professionals ( n = 38) and patients and their carers ( n = 22) to establish barriers and facilitators to clinical trial participation. Data collection took place across England and Scotland between October and December 2023. Findings from a previously published systematic review were also incorporated to inform intervention tool design. The tool was developed through an extended co‐production workshop comprising lung cancer nurses ( n = 7), lung cancer patients ( n = 2) and health researchers ( n = 4). The COM‐B model of behavioural change underpinned both phases of the project to guide tool development. Results Phase 1 focus groups identified the need for a tool to provide basic trial information to patients, and to support lung cancer nurses in discussing trials with patients, thus improving nurses' knowledge, confidence, and awareness of trials. The phase 2 coproduction workshop identified that the tool should consist of two elements: a patient‐facing information pamphlet and a large poster for nurses to assist them in discussing trial opportunities. Conclusion The study results demonstrate how nurses can be supported to discuss clinical trial opportunities with patients, with the potential to increase long‐term recruitment to clinical trials. Implications for the Profession and/or Patient Care Lung cancer nurses often lack confidence to support patients to make informed choices about trial enrolment. By addressing this issue, participation in lung cancer clinical trials can be significantly improved to benefit patient outcomes and trial participation rates. Impact The tool has the potential to be used across a range of different cancer settings and sites to increase recruitment to clinical trials. Reporting Method The COREQ checklist was utilised to ensure that robust processes were followed and reported on. Patient and Public Involvement Patients and members of the public were involved in all study processes and contributed to the study design, interpretation of the data, and intervention design. Their contributions included reviewing focus group topic guides, reviewing data analysis, the co‐production of the intervention tool, and co‐authoring this paper, ensuring the research addressed the needs and priorities of lung cancer patients when making an informed choice about clinical trial participation.
Year:
2026
Year:
2026
Introduction: Mesothelioma is a life‐limiting cancer that results in an array of psychological difficulties. While this cancer is associated with older men exposed to asbestos, it can develop in people under 60, though little research has considered the challenges and ways of supporting this younger demographic. Methods: Online semistructured interviews were carried out one‐to‐one with a total of 18 individuals; 6 men and 12 women, aged 26–59 (mean age 45), diagnosed with pleural or peritoneal mesothelioma. Participants could also share and discuss photographs to help further convey their cancer experiences. An interpretative phenomenological approach guided the analysis of transcript and photographic data. Results: Two themes with discrete subthemes are presented: “dying young of an older person’s disease,” which explores individuals’ experiences of shock at diagnosis and widespread sense of disrupted living, concern for family members, and lack of peer support, and “living young with an older person’s disease,” which explores psychobehavioral coping via focus on the atypicality of mesothelioma in young groups, return to everyday living, and via activities and exercise to manage anxiety and foster a sense of agency. Conclusion: Findings demonstrate the need to develop tailored clinical and psychotherapeutic support to address the practical and psychological difficulties younger people encounter.
Year:
2025
Peritoneal mesothelioma is a rare life-limiting cancer that is likely to have an extremely negative impact on mental health; however, no studies to date have explored the impact and needs of those living with the condition. Ten individuals diagnosed with peritoneal mesothelioma (eight women, two men) participated in interviews and could share and discuss photographs to convey their illness experiences. Data analysis was informed by Interpretative Phenomenological Analysis. Two themes are presented: ‘Experiences of Care’ and ‘Psychological Distress’. Individuals experienced a lengthy diagnostic journey with little follow-up support. Women also reported negative impacts on body image due to abdominal swelling and scaring, diminished sexual ability and loss of fertility. Individuals recalled vivid feelings of anxiety and post-traumatic stress, and tried to cope by compartmentalising their fears and modifying diets. These findings demonstrate the need to further signpost services, help individuals manage gendered issues, and alleviate feelings of anxiety.
Year:
2025
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Collaborators (4)
Catherine Henshall
Professor
Oxford Brookes University
Kerry Quincey
Senior Lecturer in Psychology
De Montfort University
Iain R. Williamson
-
Christopher Dodd
Research Associate
Newcastle University
Make your next move.
Prepare your application
Review drafts before you send them.